Ariad Pharmaceuticals Inc fka ARIA

[grandma_of_jbraika]

The Boston Globe: Ariad fears that the FDA has "created a lot of confusion and questions” among doctors and patients.

The Boston Globe news, Nov. 13, 2013:

When one analyst questioned the wisdom of publicly taking issue with US regulators, Ariad chief scientific officer Timothy P. Clackson said, “We felt obligated to, in a very careful way, explain our understanding” of the clinical data because of fears the FDA “created a lot of confusion and questions” among doctors and patients.

“The FDA cannot provide a comment, as these issues are under review,” an agency spokeswoman said Tuesday. “It’s important to note though that this action was not only based on event rates, but also the seriousness of these rates, where significant harm to patients was identified.”

Some people think the FDA obviously hate Ariad for some reason. Analyst Jason Kantor at Crédit Suisse probably agrees with bocci911 as he asked Ariad at the 2013 3Q Earnings Call :

"I really appreciate all the information on the event rates for Iclusig, but there just seems to be a pattern where FDA says one thing and then you guys come on the call publicly and say something else. So I'm just wondering, what's the logic of having this debate in a public forum? It just seems like every time you guys do that, they come down hard on you at the next possible opportunity. So I'm just wondering why you think this should be prosecuted in public rather than just in meetings with FDA?"

Is it was reported by The Boston Globe on 11/13/2013 that Ariad was publicly taking issue with US regulators again.

If Jason Kantor's observation is right, the FDA will come down even harder on Ariad at the next possible opportunity.

How hard will the FDA come down on Ariad at the next possible opportunity? Anybody has a clue?